PACB vs. LFST
PACB (Pacific Biosciences of California, Inc.) and LFST (LifeStance Health Group, Inc.) are both stocks. Both are in the Healthcare sector — PACB in Diagnostics & Research, LFST in Medical Care Facilities. Over the past 5 years, PACB returned -46.57%/yr vs -15.06%/yr for LFST. Their 0.35 correlation means their historical movements had little consistent relationship.
Performance
PACB vs. LFST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PACB achieves a -25.13% return, which is significantly lower than LFST's 48.86% return.
PACB
- 1D
- -5.41%
- 1M
- -16.67%
- 6M
- -38.05%
- YTD
- -25.13%
- 1Y
- 5.26%
- 3Y*
- -52.83%
- 5Y*
- -46.57%
- 10Y*
- -16.43%
- ALL TIME*
- -14.49%
LFST
- 1D
- -2.42%
- 1M
- -7.01%
- 6M
- 48.23%
- YTD
- 48.86%
- 1Y
- 176.52%
- 3Y*
- 3.80%
- 5Y*
- -15.06%
- 10Y*
- —
- ALL TIME*
- -11.82%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $24.32M | $33.60M | $37.81M | |
| $9.55M | $8.45M | $9.01M |
PACB vs. LFST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PACB Pacific Biosciences of California, Inc. | -25.13% | 2.19% | -81.35% | 19.93% | -60.02% | -29.57% |
LFST LifeStance Health Group, Inc. | 48.86% | -4.48% | -5.87% | 58.50% | -48.11% | -52.40% |
Correlation
The correlation between PACB and LFST is 0.29, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.29 |
Correlation (3Y) Balances recent behavior with more history. | 0.31 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.36 |
Correlation (All Time) Calculated using the full available price history since Jun 10, 2021 | 0.35 |
Fundamentals
PACB:
$434.84M
LFST:
$4.06B
PACB:
-$0.42
LFST:
$0.06
PACB:
2.65
LFST:
2.75
PACB:
4.09
LFST:
2.80
PACB:
$160.03M
LFST:
$1.49B
PACB:
$59.34M
LFST:
$323.87M
PACB:
-$146.34M
LFST:
$83.67M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PACB vs. LFST — Risk / Return Rank
PACB
LFST
PACB vs. LFST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacific Biosciences of California, Inc. (PACB) and LifeStance Health Group, Inc. (LFST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PACB | LFST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.93 | ||
| Sortino ratioReturn per unit of downside risk | -3.40 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.53 | -0.46 |
| Calmar ratioReturn relative to maximum drawdown | 0.03 | 9.63 | -9.61 |
| Martin ratioReturn relative to average drawdown | 0.04 | 21.98 | -21.93 |
Loading charts...
Drawdowns
PACB vs. LFST - Drawdown Comparison
The maximum PACB drawdown since its inception was -98.22%, which is greater than LFST's maximum drawdown of -86.91%. Use the drawdown chart below to compare losses from any high point for PACB and LFST.
Loading charts...
Drawdown Indicators
| PACB | LFST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.22% | -86.91% | -11.31% |
Max Drawdown (1Y)Largest decline over 1 year | -58.05% | -17.06% | -40.99% |
Max Drawdown (3Y)Largest decline over 3 years | -92.53% | -58.76% | -33.77% |
Max Drawdown (5Y)Largest decline over 5 years | -97.40% | -84.45% | -12.95% |
Max Drawdown (10Y)Largest decline over 10 years | -98.22% | — | — |
Current DrawdownCurrent decline from peak | -97.26% | -63.80% | -33.46% |
Average DrawdownAverage peak-to-trough decline | -70.75% | -72.49% | +1.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 33.29% | 7.47% | +25.82% |
Volatility
PACB vs. LFST - Volatility Comparison
Pacific Biosciences of California, Inc. (PACB) has a higher volatility of 16.84% compared to LifeStance Health Group, Inc. (LFST) at 10.48%. This indicates that PACB's price experiences larger fluctuations and is considered to be riskier than LFST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PACB | LFST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.84% | 10.48% | +6.36% |
Volatility (6M)Calculated over the trailing 6-month period | 54.98% | 36.59% | +18.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 85.57% | 56.09% | +29.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 94.62% | 67.28% | +27.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.90% | 67.02% | +17.88% |
Dividends
PACB vs. LFST - Dividend Comparison
Neither PACB nor LFST has paid dividends to shareholders.
Financials
PACB vs. LFST - Financials Comparison
This section allows you to compare key financial metrics between Pacific Biosciences of California, Inc. and LifeStance Health Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PACB and LFST have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PACB has higher volatility (16.84%) compared to LFST (10.48%). In terms of maximum drawdown, PACB dropped -98.22% vs LFST's -86.91%.
LFST currently has the higher Sharpe Ratio (2.95 vs 0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PACB and LFST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer